Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Asthma Spacers
... at a CAGR of 2.7% over the analysis period 2023-2030. Aerochamber Spacer, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$508.7 Million by the end of ... Read More
-
Cholesterol Testing
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
Inflammatory Bowel Disease (IBD) Therapeutics
... is expected to reach US$32.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. TNF inhibitors, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More
-
Vitamins
... of 6.0% over the analysis period 2023-2030. Vitamin B, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... the year 2023, is expected to reach US$14.0 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Sleep Apnea Diagnostic Devices, one of the segments analyzed in the report, is ... Read More
-
Bone Densitometers
... at a CAGR of 5.5% over the analysis period 2023-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$264.5 Million by the end ... Read More
-
Respiratory Care Devices
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Therapeutic Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$15.7 Billion by ... Read More
-
Diabetic Retinopathy Treatment
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Non-Proliferative Diabetic Retinopathy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$7.5 Billion ... Read More
-
Animal Medication
... at a CAGR of 4.6% over the analysis period 2023-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end ... Read More
-
Biopharmaceuticals
... of 12.3% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$310.4 Billion by the end of the analysis period. ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Asia Pacific Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) and Country Forecasts 2022-2032
... Forecasts 2022-2032 Asia Pacific Pneumococcal Vaccine Market is valued approximately USD 1.02 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.17% over the forecast period 2024-2032. The ... Read More
-
US Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) Forecasts 2022-2032
... Pneumococcal Vaccine Market is valued approximately USD 3.67 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2024-2032. The Pneumococcal Vaccine is a ... Read More
-
Global Plant-Based Multivitamins Gummies Market Growth 2024-2030
... CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “Plant-Based Multivitamins Gummies Industry Forecast” looks at past sales and reviews total world Plant-Based Multivitamins Gummies sales in 2023, providing ... Read More
-
Global Soft Gelatin Capsules (Softgels) Market Research Report 2024
... a CAGR of 3.2% during the forecast period 2024-2030. The major global manufacturers of Soft Gelatin Capsules (Softgels) include Catalent, Aenova, Nature’s Bounty, Procaps, Patheon (Thermo Fisher Scientific), Aland, EuroCaps, Captek, and Strides Pharma Science, ... Read More
-
Bone Growth Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Devices, Pulsed Electromagnetic Field (PEMF) Devices, Ultrasonic Bone Growth Stimulators}, Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP)), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial ... Read More
-
Energy-based Therapeutics
... at a CAGR of 3.7% over the analysis period 2023-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.6 Billion by the end of ... Read More
-
Compounding Pharmacies in the US - Industry Market Research Report
... the broader Healthcare and Social Assistance sector. Compounded medications can address patients' noncompliance with their medication by offering tastes, routes of administration and dosages that are not otherwise commercially available. The aging population has stimulated ... Read More
-
2024 Europe Infectious Disease Molecular Diagnostics Market for 100 Tests: France, Germany, Italy, Spain, UK - Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and ... Read More
-
Glucose Monitoring Devices Market By Device (Blood Glucose Meters, Continuous Glucose Monitoring Systems, Flash Glucose Monitoring Systems, Smartphone Apps and Wearables), By Patient Type (Type 1 Diabetes, Type 2 Diabetes) By End User (Hospitals and Clinics, Home Care Settings, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Clinics, Home Care Settings, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Glucose Monitoring Devices Market The glucose monitoring devices market was valued at $14.7 billion in 2023 and is projected to reach $38.9 ... Read More
-
Orthopedic Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$44.6 Billion by the end ... Read More
-
EEG, EMG and Evoked Potential Devices
... the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to ... Read More
-
Glucose Monitoring Devices
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Self-Monitoring Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$11.3 Billion by ... Read More